Merck agrees to let other drug makers make its Covid pill

Merck agrees to let other drug makers make its Covid pill
Merck has agreed to allow other drug makers worldwide to produce its Covid-19 pill (Merck & Co via AP)

Pharmaceutical company Merck agreed to allow other drug makers worldwide to produce its Covid-19 pill, in a move aimed at helping millions of people in poorer countries get access to the potentially life-saving drug, a United Nations-backed public health organisation said.

The Medicines Patent Pool said in a statement that it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited